In the presence of officials from the State of Iowa, Woodbury County and Sioux City - GELITA USA along with GELITA’s global management board were celebrating the recent commissioning of a new collagen peptide facility at its campus near Sioux City, Iowa. GELITA marked the facility start-up with an open-house event to offer a preview and extend thanks to those government officials, contractors, suppliers and other business associates who partnered with GELITA during the construction process.
Globally, GELITA’s collagen peptides have experienced double digit market growth – with no sign of slowing in the future. As the pioneer in collagen peptide research and production, this production expansion further secures GELITA’s position as market leader and allows for greater flexibility and future growth. This production is directly derived from raw materials using a gentle enzymatic process to create tailor-made and optimized collagen peptides, which are key ingredients in foods and nutritional supplements for their protein content and physiological benefits. Further, GELITA’s collagen peptides are supported by a robust body of scientific research making GELITA the “go-to” collagen expert in the food and health and nutrition sectors.
Pablo Silber, General Manager, GELITA USA notes, “The 30,000+ ft2 facility will – when operational at full capacity - expand the site’s production capacity by about 30% and will feature state-of-the-art technology and equipment for the production of globally demanded high quality, scientifically researched collagen peptides.” Silber also noted GELITA’s decision to expand is based upon US and global market trends and insights where collagen demand is projected for future and substantial growth.
Two years ago, GELITA’s management board reached the decision to construct this facility at GELITA’s Sioux City location due to excellent infrastructure and workforce. GELITA expects this facility to be fully operational in the upcoming months, further expanding GELITA’s global supply of collagen peptides from its broad and diverse product portfolio. As the US is a major market for these collagen peptides, this US based expansion will now position the product much closer to the US customer base.
In the US, GELITA’s operations are coordinated from the North American headquarters in Sergeant Bluff, Iowa, where now the company currently operates four separate production facilities – making it the nation’s largest single-site producer of collagen proteins. This Sergeant Bluff production capability is complimented by operations based in Calumet City, Illinois. Globally headquartered in Eberbach, Germany, GELITA – the world market leader in collagen protein production – operates more than 20 production sites around the world on five continents: North America, South America, Europe, Asia and Australia.
Globally, GELITA’s collagen peptides have experienced double digit market growth – with no sign of slowing in the future. As the pioneer in collagen peptide research and production, this production expansion further secures GELITA’s position as market leader and allows for greater flexibility and future growth. This production is directly derived from raw materials using a gentle enzymatic process to create tailor-made and optimized collagen peptides, which are key ingredients in foods and nutritional supplements for their protein content and physiological benefits. Further, GELITA’s collagen peptides are supported by a robust body of scientific research making GELITA the “go-to” collagen expert in the food and health and nutrition sectors.
Pablo Silber, General Manager, GELITA USA notes, “The 30,000+ ft2 facility will – when operational at full capacity - expand the site’s production capacity by about 30% and will feature state-of-the-art technology and equipment for the production of globally demanded high quality, scientifically researched collagen peptides.” Silber also noted GELITA’s decision to expand is based upon US and global market trends and insights where collagen demand is projected for future and substantial growth.
Two years ago, GELITA’s management board reached the decision to construct this facility at GELITA’s Sioux City location due to excellent infrastructure and workforce. GELITA expects this facility to be fully operational in the upcoming months, further expanding GELITA’s global supply of collagen peptides from its broad and diverse product portfolio. As the US is a major market for these collagen peptides, this US based expansion will now position the product much closer to the US customer base.
In the US, GELITA’s operations are coordinated from the North American headquarters in Sergeant Bluff, Iowa, where now the company currently operates four separate production facilities – making it the nation’s largest single-site producer of collagen proteins. This Sergeant Bluff production capability is complimented by operations based in Calumet City, Illinois. Globally headquartered in Eberbach, Germany, GELITA – the world market leader in collagen protein production – operates more than 20 production sites around the world on five continents: North America, South America, Europe, Asia and Australia.
